Dr. Madhuradhar Chegondi, MBBS, MD
Claim this profileUniversity of Iowa Health Care
Studies Blood Clot
Studies Transfusion reaction
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Madhuradhar Chegondi, MBBS, MD is currently running
Platelet Transfusion
for Bleeding in Children on ECMO
Critically ill children supported by extracorporeal membrane oxygenation (ECMO) receive large volumes of prophylactic platelet transfusions to prevent bleeding. However, mounting evidence has demonstrated significant morbidity and mortality associated with these transfusions. The ECmo hemoSTAtic Transfusions In Children (ECSTATIC) pilot trial will test two different platelet transfusion strategies, based on two different platelet counts thresholds, one high (higher platelet transfusion strategy) and one low (lower platelet transfusion strategy). The pilot will gather the necessary information to perform a full trial which will provide a better understanding of how to transfuse platelets to children supported by ECMO and reduce the associated morbidity.
Recruiting3 awards Phase 42 criteria
Enoxaparin
for Blood Clot Prevention
The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.
Recruiting1 award Phase 2 & 33 criteria
More about Madhuradhar Chegondi, MBBS, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Madhuradhar Chegondi, MBBS, MD has experience with
- Platelet Transfusion
- Enoxaparin
Breakdown of trials Madhuradhar Chegondi, MBBS, MD has run
Transfusion reaction
Thromboembolic Disorders
Extracorporeal Membrane Oxygenation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Madhuradhar Chegondi, MBBS, MD specialize in?
Madhuradhar Chegondi, MBBS, MD focuses on Blood Clot and Transfusion reaction. In particular, much of their work with Blood Clot has involved treating patients, or patients who are undergoing treatment.
Is Madhuradhar Chegondi, MBBS, MD currently recruiting for clinical trials?
Yes, Madhuradhar Chegondi, MBBS, MD is currently recruiting for 2 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Madhuradhar Chegondi, MBBS, MD has studied deeply?
Yes, Madhuradhar Chegondi, MBBS, MD has studied treatments such as Platelet Transfusion, Enoxaparin.
What is the best way to schedule an appointment with Madhuradhar Chegondi, MBBS, MD?
Apply for one of the trials that Madhuradhar Chegondi, MBBS, MD is conducting.
What is the office address of Madhuradhar Chegondi, MBBS, MD?
The office of Madhuradhar Chegondi, MBBS, MD is located at: University of Iowa Health Care, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa Health Care.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.